Skeletal bone lesion and the effectiveness of Bonephos (clodronate) in the comprehensive therapy of multiple myeloma
Bessmel'tsev, S.S.; Abdulkadyrov, K.M.
Voprosy Onkologii 42(4): 12-18
1996
ISSN/ISBN: 0507-3758 PMID: 8928450 Document Number: 463109
Document emailed within 1 workday
Related Documents
Adam, Z.; Prokes, B.; Znojĭl, V.; Vorlícek, J.; Hejlová, N.; Hájek, D.; Krejcí, M. 1996: The effect of clodronate on bone density in patients with multiple myeloma--a 2-year follow-up of therapeutic effects Vnitrni Lekarstvi 42(6): 379-385Showalter, K.; Maize, J.; Altomare, I.; Fisher, G. 2013: Multiple myeloma diagnosed secondary to analysis of a lytic bone lesion encountered during Mohs micrographic surgery Dermatology Online Journal 19(8): 19262
Adam, Z.; Prokes, B.; Hájek, D.; Vorlícek, J. 1995: Increasing bone density in myeloma patients after the administration of clodronate Acta Medica Austriaca 22(1-2): 9-12
Lastůvková, I.; Adam, Z. 2002: A questionnaire survey of tolerance and adverse effects of clodronate (Bonefos) in patients with multiple myeloma Vnitrni Lekarstvi 48(11): 1049-1053
Gordovskaia, N.B.; Kravets, T.A.; Tareeva, I.E. 1986: Kidney lesion in multiple myeloma Terapevticheskii Arkhiv 58(8): 45-48
Dhanrajani, P.J.; Abdulkarim, S.A. 1997: Multiple myeloma presenting as a periapical lesion in the mandible Indian Journal of Dental Research: Official Publication of Indian Society for Dental Research 8(2): 58-61
Mian, M.; Beghé, F.; Caprio, A.; Aloj, R.; Bertelli, A. 1991: Tolerability and safety of clodronate therapy in bone diseases International Journal of Clinical Pharmacology Research 11(2): 107-114
Vorreuther, R.; Klotz, T.; Engelking, R. 1992: Clodronate in the palliative therapy of bone-metastasized prostatic carcinoma Der Urologe. Ausg. a 31(2): 63-66
Barlogie, B.; Alexanian, R. 1989: Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma Cancer Research 49(24 Pt 1): 7172-7175
Botturi, M.; Zanni, D.; Tosi, G. 1990: Drug therapy with disodium clodronate combined with radiotherapy of bone metastasis of solid tumors La Radiologia Medica 80(5): 726-733
Oken, M.M.; Lenhard, R.E.; Tsiatis, A.A.; Glick, J.H.; Silverstein, M.N. 1987: Contribution of prednisone to the effectiveness of hexamethylmelamine in multiple myeloma Cancer Treatment Reports 71(9): 807-811
Mehta, J.; Duff, S.B.; Gupta, S. 2004: Cost effectiveness of bortezomib in the treatment of advanced multiple myeloma Managed Care Interface 17(9): 52-61
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Abe, M. 2006: Bone disease in multiple myeloma and its mechanism Clinical Calcium 16(4): 565
Hata, H.; Mitsuya, H. 2006: Management of bone lesions in multiple myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(8): 1072-1076
Murthy, N.J.; Rao, H.; Friedman, A.S. 2000: Positive findings on bone scan in multiple myeloma Southern Medical Journal 93(10): 1028-1029
Neuwirtová, R.; Stĕpán, J.; Pacovský, V.; Formánková, J.; Jarolímková, E. 1983: Biochemical monitoring of bone involvement in multiple myeloma Vnitrni Lekarstvi 29(7): 630-637
Wong, D.F.; Bobechko, P.E.; Becker, E.J.; Howe, G.R. 1981: Coexistent multiple myeloma and Paget's disease of bone Journal of the Canadian Association of Radiologists 32(4): 251-253
Gahrton, G. 1999: Allogeneic bone marrow transplantation in multiple myeloma Pathologie-Biologie 47(2): 188-191
Rizzo, M.; Meli, C.; Bonanno, M.; Maccarrone, S.; Guglielmo, P. 1981: Bone marrow T-lymphocyte subpopulations in patients with multiple myeloma Bollettino della Societa Italiana di Biologia Sperimentale 57(6): 678-684